Preferred Label : Bevacizumab/Cisplatin/Paclitaxel Regimen;
NCIt synonyms : Platinol/Taxol/Avastin Regimen; Platinol-Taxol-Avastin Regimen; Cisplatin/Paclitaxel/Bevacizumab; Cisplatin-Paclitaxel-Bevacizumab; Cisplatin-Paclitaxel-Bevacizumab Regimen; Cisplatin/Paclitaxel/Bevacizumab Regimen;
NCIt related terms : Cisplatin, Paclitaxel, Bevacizumab; Cisplatin, Paclitaxel, Bevacizumab-adcd; Cisplatin, Paclitaxel, Bevacizumab-bvzr; Cisplatin, Paclitaxel, Bevacizumab-equi; Cisplatin, Paclitaxel, Bevacizumab-awwb; Cisplatin, Paclitaxel, Bevacizumab-aybi; Cisplatin, Paclitaxel, Bevacizumab-maly; Cisplatin, Paclitaxel, Bevacizumab-onbe;
NCIt definition : A regimen consisting of bevacizumab, cisplatin and paclitaxel that is used for the
treatment of vulvar and cervical cancer.;
NCI Metathesaurus CUI : CL523552;
Codes from synonyms : 11505; 127389; 127241; 127463; 127167; 127611; 127315; 127537;
Origin ID : C136241;
UMLS CUI : C4526515;
Est indiqué pour
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset
regimen_has_accepted_use_for_disease